Business Development Director, Europe, GSK
Jeremy is a Senior Director in GSK R&D's Worldwide Business Development Team, with a focus on identifying and evaluating innovative emerging science, drugs and technologies aligned with GSK's R&D strategy.
Jeremy is a biologist by training and is a Fellow of the Royal Society of Biology. He has extensive knowledge of the drug discovery process, drawn from over fifteen years of post-doctoral experience in the pharmaceutical industry and has a broad-ranging professional network within Industry and Academia.
Beyond his GSK role, Jeremy is an appointed Expert-in-Residence at the University of Cambridge, providing advice and industrial perspectives to academics interested in translating their discoveries into new medicines. He also lectures periodically at Cambridge on Oncology Therapeutics and Drug Discovery and serves on the Council of Governors of Cambridge University Hospitals NHS Foundation Trust.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557